Clinical trials in progress with hormone replacement therapy

Expert Opinion on Investigational Drugs

Volumn 5, Issue 6, 1996, Pages 739-749

  Spencer, C P ^a   Cooper, A J ^a   Stevenson, J C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

cardiovascular disease; hormone replacement therapy; lipoproteins; oestrogen

Indexed keywords

EID: 0000697941     PISSN: 13543784     EISSN: 17447658     Source Type: Journal    
DOI: 10.1517/13543784.5.6.739     Document Type: Review

References (34)

1. STAMPFER MJ, COLDTIZ GA: Estrogen replacement therapy and coronary disease: a quantitative assessment of the epidemiological evidence. Prev. Med. (1991) 20:47-63.
2. BUSH TL, BARRETT-CONNOR E, COWAN LD et al: Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program follow-up study. Circulation (1987) 75:1102-1109. (Pubitemid 17081015)
3. ETTINGER B, GENANT HK, CANN CE: Long-term estrogen therapy prevents bone loss and fracture. Ann. Intern. Med. (1985) 102:319-324. (Pubitemid 15134678)
4. WHITEHEAD MI, TOWNSEND PT, PRYSE-DAVIES J, RYDER TA, KING RJB: Effects of estrogens and progestins on the biochemistry and morphology of the human endometrium. New Engl. J. Med. (1981) 305:1599-1605. (Pubitemid 12169187)
5. SCHWARTZ J, FREEMAND R, FRISHMAN W: Clinical pharmacology of estrogens: cardiovascular actions and cardioprotective benefits of replacement therapy in postmenopausal women. J. Clin. Pharmacol. (1995) 35:314-329.
6. PEARSON TA, BULKLEY BH, ACHUFF SC, KWITEROVICH PL, GORDIS L: The association of low levels of HDL-cho-lcsterol and arteriographically defined coronary artery disease. Am. J. Epidemiol, (1979) 109:285-295. (Pubitemid 10209604)
7. THE WRITING GROUP FOR THE PEPI TRIAL: Effects of estrogen/progestln regimens on heart disease risk factors In postmenopausal women. JAMA (1995) 273:199-208.
8. CROOK D, CUST MP, GANGAR KF et al.: Comparison of transdermal and oral oestrogen-progestin replacement therapy: effects on lipids and lipoproteins. Am. J. Obstel. Gynaecol. (1992) 166:950-955.
9. GRADY D, RUBIN, SM, PETTITI DB et al.: Hormone therapy to prevent disease and prolong life In postmenopausal women. Ann. Intern. Med. (1992) 117:1016-1037.
10. PSATY BM, HECKBERT SR, ATKINS D et al: The risk of myocardial Infarction associated with combined use of estrogens and progestins in postmenopausal women. Arch. Intern. Med. (1994) 154:1333-1339. (Pubitemid 24197677)
11. NABULSI AA, FOLSOM AR, WHITE A et al: Association of hormone-replacement therapy 'with various cardiovascular risk factors in post-menopausal women. New Engl. J. Med. (1993) 328:1069-1075. (Pubitemid 23097795)
12. FALKEBORN M, PERSSON I, ADAMI HO et al: The risk of acute myocardial infarction after oestrogen and oestro-gen-progesteron replacement. Br. J, Obstet. Gynaecol. (1992) 99:821-628.
13. HULKA BS: Links between hormone replacement therapy and neoplasia. Fertil Steril. (1994) 62(Suppl. 2):168S-175S. (Pubitemid 24366575)
14. VOIGT LF, WEISS NS, CHU J et al: Progestogen supplementation of exogenous oestrogens and risk of endometrial cancer. Lancet (1991) 338:274-277.
15. SMITH DC, PRENTICE R, THOMPSON DJ, HERMANN WL: Association of exogenous estrogen and endometrial carcinoma. New Engl. J. Med. (1975) 293:1164-1167.
16. GURA T: Estrogen: key player in heart disease among women. Science (1995) 269:771-8773.
17. KANNEL WB, SORLIE P, MCNAMARA PM: Prognosis after myocardial infarction: the Framingham Study. Am. J. Cardiol. (1979) 44:53-59. (Pubitemid 9216892)
18. PAGANINI-HILL A: Estrogen replacement therapy and stroke. Prog. Cardiovasc. Dis. (1995) 38:223-242.
19. HEALY B: PEPI In perspective. Good answers spawn pressing questions. JAMA (1995) 273:240-241.
20. SULIVAN J, ZWAAG RV, LEMP GF et al: Post-menopausal oestrogen use and coronary atherosclerosis. Ann. Intern. Med. (1988) 108:358-363.
21. HONG MK, ROMM PA, REAGAN K GREEN CE, RACKLEY CE: Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in post-menopausal women. Am. J. Cardiol. (192) 69:176-178.
22. GRUCHOW HW, ANDERSON AJ, BARBORIAK JJ, SOBOCVINSKIKA: Post-menopausal use of estrogen and occlusion of coronary arteries. Am. Heart. J. (1988) 115:954-963.
23. KNOPP RH, ZHU X, BONET B: Effects of estrogens on lipid metabolism and cardiovascular disease in women. Atherosclerosis (1994) 110(Suppl.):S83-S91.
24. ROSSOUW JE, FINNEGAN LP, HARLAN WR et al: The evolution of the women's health initiative: perspectives from the NIH. J. Am. Med. Worn. Assoc. (1995) 50:50-55.
25. CUMMINGS NB: Women's health and nutrition research: US governmental concerns. J. Am. Coll. Nutr. (1993) 12:329-336. (Pubitemid 23228277)
26. PALCA J: NIH unveils plan for women's health project. Science (1991) 254:792.
27. FINNEGAN LP, ROSSOUW J, HARLAN WR: A peppy response to PEPI results. Nature Medicine (1995) 1:205-206.
28. VASSILOPOULOU-SELLIN R, THERIAULT RL: Randomised prospective trial of estrogen replacement therapy in women-with a history of breast cancer [Monograph]. Natl. Cancer Inst. (1994) 16:153-159.
29. CERIN A, HELDAS K, MOELLER B: Adverse endometrial effects on long-cycle estrogen and progestogen replacement therapy. New Engl. J. Med. (1996) 334:668-669. (Pubitemid 26072134)
30. WHITEHEAD MI: The effects of estrogens and progestogens on the post-menopausal endometrium. Maturitas (1978) 1:87-98. (Pubitemid 9071847)
31. WHITEHEAD MI, TOWNSEND PT, PRYSE-DAVIES J et al: Effects of various types and dosages of progestogens on the post-menopausal endometrium. J. Reprod. Med. (182) 27:539-548.
32. FDA HRT WORKING GROUP: Guidance for clinical evaluation of combination estrogen/progestin containing drug products used for hormone replacement therapy of post-menopausal'women. Menopause: The Journal of the North American Menopause Society (1995) 2:131-136.
33. AMERICAN COLLEGE OF OBSTETRICS AND GYNECOLOGY: Hormone replacement therapy. ACOG Tech. Bull. (1992) 166:1-8.
34. VICKERS MR, MEADE TW, WILKES HC: Hormone replacement therapy and cardiovascular disease: the case for a randomised controlled trial. In: Non-reproductive Actions of Sex Steroids. Wiley, Chichester. Ciba Foundation Symposium (1995) 191:150-164.